Show simple item record

dc.contributor.authorYildiz G.
dc.contributor.authorKayataş M.
dc.contributor.authorCandan F.
dc.date.accessioned2019-07-27T12:10:23Z
dc.date.accessioned2019-07-28T09:14:44Z
dc.date.available2019-07-27T12:10:23Z
dc.date.available2019-07-28T09:14:44Z
dc.date.issued2011
dc.identifier.issn1300-7718
dc.identifier.urihttps://dx.doi.org/10.5262/tndt.2011.1002.02
dc.identifier.urihttps://hdl.handle.net/20.500.12418/4980
dc.description.abstractHyponatremia is the most common electrolyte abnormality encountered in clinical practice. The symptoms of hyponatraemia are largely dependent on the rapidity of the development of hyponatraemia. Acute symptomatic hyponatremia is a serious clinical situation. The pathogenesis of hyponatremia has been found to occur secondary to the nonosmotic secretion of ADH in over 95% of cases. In other words, hyponatremia caused by more water imbalance than sodium imbalance in the majority of cases. Pseudohyponatremia(elevation of lipids or proteins in plasma causing artifactual decrease in serum sodium concentration) and translocational hyponatremia(the additional solutes in plasma such as glucose, mannitol and radiographic contrast agent causing osmotic shift of water from intracellular fluid to extracellular fluid) that are not associated excess are excluded on the first step in the differential diagnosis of hyponatraemia. While only fluid restriction is sufficient for treatment of asymptomatic patients, emergency treatment should be given in symptomatic patients. Recently ADH receptor antagonists have been used as an alternative treatment of saline infusion in the treatment of euvolemic and hypervolemic hyponatremia. Correction rate of sodium should be 0,5-1mEq/L/h in the treatment of hyponatremia. Rapidly correction should be avoided in hyponatraemia, because it can lead to celebral hemorrhage and central pontine myelinolysis.en_US
dc.description.sponsorshipYildiz, G.; Cumhuriyet Üniversitesi, Tip Fakültesi, Nefroloji Anabilim Dali, Sivas, Turkey; email: drgursel@yahoo.comen_US
dc.language.isoturen_US
dc.relation.isversionof10.5262/tndt.2011.1002.02en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectADH receptor antagonistsen_US
dc.subjectHyponatremiaen_US
dc.subjectPontine myelinolysisen_US
dc.subjectSyndrome of inappropriate antidiuretic hormone secretionen_US
dc.titleHyponatremia; current diagnosis and treatment [Hiponatremi; güncel tani ve tedavisi]en_US
dc.typereviewen_US
dc.relation.journalTurkish Nephrology, Dialysis and Transplantation Journalen_US
dc.contributor.departmentYildiz, G., Cumhuriyet Üniversitesi, Tip Fakültesi, Nefroloji Anabilim Dali, Sivas, Turkey -- Kayataş, M., Cumhuriyet Üniversitesi, Tip Fakültesi, Nefroloji Anabilim Dali, Sivas, Turkey -- Candan, F., Cumhuriyet Üniversitesi, Tip Fakültesi, Nefroloji Anabilim Dali, Sivas, Turkeyen_US
dc.identifier.volume20en_US
dc.identifier.issue2en_US
dc.identifier.endpage131en_US
dc.identifier.startpage115en_US
dc.relation.publicationcategoryDiğeren_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record